BioSpace News Archive

Syndax Pharmaceuticals, Inc. announced today that it will release its third quarter 2021 financial results on Monday, November 15, after the close of the U.S. financial markets.

Q32 Bio, a clinical stage biotechnology company developing biologic therapeutics to restore immune homeostasis, today announced preclinical data from the Company’s lead program for innate immunity, ADX-097, presented at the American Society of Nephrology (ASN) Kidney Week 2021 on November 5, 2021.

ATP, a leader in life sciences venture capital, today announced the launch of Marengo Therapeutics, Inc.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced additional positive results from a Phase 3 trial jointly run with the National Institute of Allergy and Infectious Diseases (NIAID), which assessed use of a single dose of investigational REGEN-COV® (1,200 mg administered via 4 subcutaneous injections) to prevent COVID-19 in uninfected individuals.

Braxia Scientific Corp. is delighted to announce that its CEO, Dr. Roger McIntyre , has been selected to be a keynote speaker at the Wonderland: Miami conference.

Taysha Gene Therapies, Inc. today announced its participation in the following events: Stifel 2021 Virtual Healthcare Conference on November 15, 2021 at 11:20 am ET Jefferies London Healthcare Conference November 17, 2021 at 12:20 pm GMT 4th Annual Evercore ISI HealthCONx Virtual Conference on November 30, 2021 at 4:20 pm ET

NewAmsterdam Pharma today announced that its Phase 2 Randomized Study of Obicetrapib as an Adjunct to High Intensity Statin Therapy

AVROBIO to Present Clinical and Preclinical Data at the 14th ICIEM Conference

LENSAR, Inc. today announced financial results for the quarter ended September 30, 2021.

The body contouring devices market has been anticipated to experience significant growth avenues in the forthcoming years.